Oxidative stress, sperm survival and fertility control
Reduced Healthcare Inequality: Lower prices mean that life-saving diabetes and obesity treatments will no longer be a luxury reserved for the wealthy
Mil-GuaschMRamrezSLlanaSRFos-DomnechJDropmannLMPozoMet al
Our work focuses on addressing interconnected issues such as weight gain, fatigue, brain fog, and hormonal imbalances by uncovering and correcting their root causes
NichollsSJBhattDLBuseJBPratoSDKahnSELincoffAMet alComparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics
US-based Eli Lilly & Co., Novos main rival, has also gained Chinese approval for its weight-loss drug, while domestic biotech companies are working on competing candidates